Tumor Characteristic Group | Gene | Median Methylation Levelof the Gene | Adaptive Hochberg p-value for the Wilcoxon ranked sum tests | |
---|---|---|---|---|
ER | ER+ | ER- | ||
RIL | 16.75% | 21.90% | 0.58 | |
HIN-1 | 17.00% | 7.90% | 0.002 | |
RASSF1A | 23.10% | 8.90% | <0.001 | |
CDH13 | 8.60% | 8.35% | 0.58 | |
PR | PR+ | PR- | ||
RIL | 14.70% | 24.65% | 0.012 | |
HIN-1 | 19.50% | 8.60% | 0.002 | |
RASSF1A | 23.10% | 13.4% | 0.019 | |
CDH13 | 8.60% | 8.70% | 0.14 | |
Tumor Size | ≤ 2 cm | >2 cm | ||
RIL | 15.45% | 21.30% | 0.002 | |
HIN-1 | 12.10% | 16.30% | 0.45 | |
RASSF1A | 13.60% | 21.40% | 0.09 | |
CDH13 | 7.30% | 9.65% | 0.002 | |
S-phase | ≤ 10% | > 10% | ||
RIL | 14.80% | 24.55% | 0.036 | |
HIN-1 | 16.10% | 12.65% | 0.39 | |
RASSF1A | 18.50% | 15.30% | 0.17 | |
CDH13 | 7.05% | 9.30% | 0.31 | |
Ploidy | Diploid | Aneuploid | ||
RIL | 14.80% | 23.70% | < 0.001 | |
HIN-1 | 12.45% | 16.20% | 0.30 | |
RASSF1A | 14.90% | 17.90% | 0.93 | |
CDH13 | 7.10% | 8.80% | 0.07 |